Andrea Smith of HCA (NYSE: HCA) receives 509-share director equity award

Rhea-AI Filing Summary

Smith Andrea B reported acquisition or exercise transactions in this Form 4 filing.

HCA Healthcare, Inc. director Andrea B. Smith reported receiving an equity-based compensation award in the form of 509 restricted share units of common stock. These units are part of an annual director equity award and carry a grant price of $0.00 per share, reflecting compensation rather than a market purchase.

The award will vest on the earlier of the company’s 2027 annual shareholders’ meeting or the first anniversary of the grant date. Vested shares will be delivered when she ceases to serve on HCA’s Board of Directors. Following this grant, she directly holds 4,666 shares of common stock.

Separately, 82 shares are reported as held in fully managed accounts over which Smith has no investment authority. She disclaims beneficial ownership of those managed-account shares except to the extent of her pecuniary interest.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Smith Andrea B

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	509	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 4,666 shares (Direct, null); Common Stock — 82 shares (Indirect, By managed accounts)

Footnotes (1)

1. Represents common stock underlying 509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. The shares reported herein are held in fully managed accounts over which the Reporting Person does not have any investment authority. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of her pecuniary interest therein.

Key Figures

Restricted share units granted: 509 units Grant price per share: $0.00 per share Direct holdings after grant: 4,666 shares +2 more

5 metrics

Restricted share units granted 509 units Annual director equity award in HCA common stock

Grant price per share $0.00 per share Restricted share unit compensation grant, not market purchase

Direct holdings after grant 4,666 shares HCA common stock directly owned by Andrea B. Smith

Indirect managed-account shares 82 shares Held in fully managed accounts; no investment authority, beneficial ownership disclaimed except pecuniary interest

Vesting timing By 2027 shareholders’ meeting or 1 year Units vest on earlier of 2027 annual meeting or first anniversary of grant

Key Terms

restricted share units, annual director equity award, managed accounts, pecuniary interest

4 terms

restricted share units financial

"Represents common stock underlying 509 restricted share units attributable to an annual director equity award"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

annual director equity award financial

"509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting"

managed accounts financial

"The shares reported herein are held in fully managed accounts over which the Reporting Person does not have any investment authority"

Managed accounts are collections of investments owned by an individual or institution but run day-to-day by a professional who buys, sells and allocates assets according to an agreed plan. They matter to investors because they provide tailored oversight, active risk control and potential tax efficiency—like hiring a personal chef to manage your diet—while fees and the manager’s skill directly affect returns.

pecuniary interest financial

"The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of her pecuniary interest therein"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith Andrea B

(Last) (First) (Middle)

ONE PARK PLAZA

(Street)

NASHVILLE TENNESSEE 37203

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [ HCA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/28/2026		A(1)		509	A	$0	4,666	D
Common Stock								82	I	By managed accounts(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents common stock underlying 509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.

2. The shares reported herein are held in fully managed accounts over which the Reporting Person does not have any investment authority. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of her pecuniary interest therein.

	/s/ Kevin A. Ball, Attorney-in-Fact	04/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did HCA (HCA) director Andrea B. Smith report in this Form 4?

Andrea B. Smith reported receiving 509 restricted share units of HCA common stock as an annual director equity award. The units were granted at $0.00 per share as compensation and increase her direct holdings to 4,666 shares after the transaction.

How and when do Andrea B. Smith’s 509 HCA restricted share units vest?

The 509 restricted share units vest on the earlier of HCA’s 2027 annual shareholders’ meeting or the first anniversary of the grant date. Once vested, the underlying shares are scheduled to be delivered when she ceases serving on HCA’s Board of Directors.

How many HCA shares does Andrea B. Smith hold after this equity award?

After the award, Andrea B. Smith directly holds 4,666 shares of HCA common stock. An additional 82 shares are reported in fully managed accounts, where she has no investment authority and disclaims beneficial ownership except for any pecuniary interest she may have.

What is the nature of the 82 HCA shares held in managed accounts for Andrea B. Smith?

The 82 HCA shares are held in fully managed accounts over which Andrea B. Smith has no investment authority. She expressly disclaims beneficial ownership of these shares, except to the extent of her pecuniary interest, meaning her economic stake but not control rights.

Is Andrea B. Smith’s 509-share HCA award a market purchase or compensation grant?

The 509-share HCA award is a compensation grant, not a market purchase. It is described as an annual director equity award in restricted share units, with a transaction price of $0.00 per share, reflecting non-cash stock-based compensation rather than an open-market transaction.